Plant-based medicinal compounds or nutritional supplements in various carrier combinations are described. The carriers can include N-acylated fatty amino acids, penetration enhancers, and/or various other beneficial carriers. The plant-based composition/carrier combinations can create administration benefits.
A61K 9/48 - Preparations in capsules, e.g. of gelatin, of chocolate
A61K 31/00 - Medicinal preparations containing organic active ingredients
A61K 31/047 - Hydroxy compounds, e.g. alcoholsSalts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
A61K 31/20 - Carboxylic acids, e.g. valproic acid having a carboxyl group bound to an acyclic chain of seven or more carbon atoms, e.g. stearic, palmitic or arachidic acid
A61K 31/353 - 3,4-Dihydrobenzopyrans, e.g. chroman, catechin
A61K 31/352 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
A23L 33/105 - Plant extracts, their artificial duplicates or their derivatives
A61K 9/00 - Medicinal preparations characterised by special physical form
A61K 9/48 - Preparations in capsules, e.g. of gelatin, of chocolate
A61K 31/20 - Carboxylic acids, e.g. valproic acid having a carboxyl group bound to an acyclic chain of seven or more carbon atoms, e.g. stearic, palmitic or arachidic acid
Particles, aqueous dispersions, and compositions having high lipophilic component (LC) concentrations and high LC to surfactant ratios are described. The particles, aqueous dispersions, and compositions can be used to efficiently deliver active compounds and/or active ingredients through a variety of formulation types.
A61K 9/1272 - Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
C07J 17/00 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta[a]hydrophenanthrene skeleton
A61K 31/122 - Ketones having the oxygen atom directly attached to a ring, e.g. quinones, vitamin K1, anthralin
A61K 47/22 - Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
4.
PARTICLES, AQUEOUS DISPERSIONS, AND LIQUID COMPOSITIONS HAVING HIGH LIPOPHILIC COMPONENT CONCENTRATIONS AND HIGH LIPOPHILIC COMPONENT TO SURFACTANT RATIOS
Particles, aqueous dispersions, and liquid compositions having high lipophilic component concentrations and high lipophilic component to surfactant ratios are described. The particles, aqueous dispersions, and liquid compositions can be used to efficiently deliver active compounds and/or active ingredients, such as cannabinoids including cannabidiol (CBD), through a variety of formulation types.
Formulations having a glycoside and a high lipophilic component (LC) to surfactant ratio are described. The formulations can be used to efficiently deliver LC through a variety of formulation types, including beverages.
A61K 31/352 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
A23L 33/105 - Plant extracts, their artificial duplicates or their derivatives
A61K 47/26 - Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharidesDerivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
Plant-based medicinal compounds or nutritional supplements in various carrier combinations are described. The carriers can include N-acylated fatty amino acids, penetration enhancers, and/or various other beneficial carriers. The plant-based composition/carrier combinations can create administration benefits.
A61K 31/352 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
A61K 9/00 - Medicinal preparations characterised by special physical form
Particles, aqueous dispersions, and compositions having high lipophilic component (LC) concentrations and high LC to surfactant ratios are described. The particles, aqueous dispersions, and compositions can be used to efficiently deliver active compounds and/or active ingredients through a variety of formulation types.
Plant-based medicinal compounds or nutritional supplements in various carrier combinations are described. The carriers can include N-acylated fatty amino acids, penetration enhancers, and/or various other beneficial carriers. The plant-based composition/carrier combinations can create administration benefits.
A61K 9/48 - Preparations in capsules, e.g. of gelatin, of chocolate
A61K 31/047 - Hydroxy compounds, e.g. alcoholsSalts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
A61K 31/20 - Carboxylic acids, e.g. valproic acid having a carboxyl group bound to an acyclic chain of seven or more carbon atoms, e.g. stearic, palmitic or arachidic acid
A61K 31/352 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
A61K 31/353 - 3,4-Dihydrobenzopyrans, e.g. chroman, catechin
03 - Cosmetics and toiletries; cleaning, bleaching, polishing and abrasive preparations
Goods & Services
Cosmetics; Body and beauty care cosmetics; Cold cream for cosmetic purposes; Cosmetic creams; Cosmetic massage creams; Cosmetic nourishing creams; Cosmetic oils; Cosmetic preparations; Cosmetic preparations for body care; Cosmetic preparations for skin care; Cosmetic preparations, namely, firming creams; Cosmetic preparations, namely, firming lotions; Cosmetic suntan preparations; Cosmetics and cosmetic preparations; Face creams for cosmetic use; Lotions for cosmetic purposes; Non-foaming cosmetic preparations for skin; Non-medicated cosmetics; Oils for cosmetic purposes; Serums for cosmetic purposes; Skin and body topical lotions, creams and oils for cosmetic use; Skin hydrating preparations for cosmetic purposes; Skin moisturizers used as cosmetics; Topical herbal extracts for cosmetic purposes; Topical skin sprays for cosmetic purposes.
Herbal compositions in various carrier combinations are described. The carriers can include N-acylated fatty amino acids, penetration enhancers, and/or various other beneficial carriers. The herbal composition/carrier combinations can create administration benefits.
A61K 31/122 - Ketones having the oxygen atom directly attached to a ring, e.g. quinones, vitamin K1, anthralin
A61K 31/20 - Carboxylic acids, e.g. valproic acid having a carboxyl group bound to an acyclic chain of seven or more carbon atoms, e.g. stearic, palmitic or arachidic acid
Synthetic cannabinoid medicinal compounds or nutritional supplements in various carrier combinations are described. The carriers can include N-acylated fatty amino acids, penetration enhancers, and/or various other beneficial carriers. The synthetic cannabinoid composition/carrier combinations can create administration benefits.
A61K 31/352 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
A23L 33/105 - Plant extracts, their artificial duplicates or their derivatives
A61K 9/00 - Medicinal preparations characterised by special physical form
A61K 31/192 - Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
12.
PARTICLES, AQUEOUS DISPERSIONS, AND LIQUID COMPOSITIONS HAVING HIGH LIPOPHILIC COMPONENT CONCENTRATIONS AND HIGH LIPOPHILIC COMPONENT TO SURFACTANT RATIOS
Particles, aqueous dispersions, and liquid compositions having high lipophilic component concentrations and high lipophilic component to surfactant ratios are described. The particles, aqueous dispersions, and liquid compositions can be used to efficiently deliver active compounds and/or active ingredients, such as cannabinoids including cannabidiol (CBD), through a variety of formulation types.
Particles, aqueous dispersions, and liquid compositions having high lipophilic component concentrations and high lipophilic component to surfactant ratios are described. The particles, aqueous dispersions, and liquid compositions can be used to efficiently deliver active compounds and/or active ingredients, such as cannabinoids including cannabidiol (CBD), through a variety of formulation types.
03 - Cosmetics and toiletries; cleaning, bleaching, polishing and abrasive preparations
05 - Pharmaceutical, veterinary and sanitary products
29 - Meat, dairy products, prepared or preserved foods
30 - Basic staples, tea, coffee, baked goods and confectionery
32 - Beers; non-alcoholic beverages
Goods & Services
Bath additives, namely, bath beads, bath bombs, bath
crystals and bubble bath; bath herbs; bath oils; bath oils
for cosmetic purposes; beauty care cosmetics; beauty creams
for body care; beauty gels; beauty lotions; body and beauty
care cosmetics; body creams; body oils; cosmetic creams;
cosmetic oils; cosmetics and make-up; face and body lotions;
face and body milk; face lotion; hair care preparations;
hair styling preparations; hand cream; hand lotions;
non-medicated lip care preparations; non-medicated lip
conditioners; lip glosses; non-medicated liquid soaps;
massage creams; massage oils; non-medicated bubble bath
preparations; non-medicated preparations for the care of
hair; non-medicated preparations for the care of skin;
non-medicated preparations for the care of the scalp;
non-medicated skin care preparations; non-medicated skin
care preparations for skin brightening; non-medicated skin
care preparations for reducing inflammation; oils for
toiletry purposes; skin creams; skin emollients; skin
lotions; skin soap; non-medicated soaps for body care;
non-medicated soaps for personal use; breath freshening
sprays; eye compresses for cosmetic purposes; eye creams,
lotions and gels for cosmetic purposes; eye pads and patches
for cosmetic use, namely, eye compresses and gel eye patches
for cosmetic purposes; fragrance sachets for eye pillows;
all of the foregoing containing lipophilic plant extracts
and synthetic equivalents thereof. Medicated oils, salves, and concentrated pastes, namely,
medicated skin care preparations; dietary supplements;
nutraceuticals for use as a dietary supplement; medicated
oils, salves, and concentrated pastes, namely, medicated
skin care preparations, all of the foregoing containing
lipophilic plant extracts and synthetic equivalents thereof;
medicated oils, salves, and concentrated pastes, namely,
medicated skin care preparations, oils, salves, concentrated
pastes, tinctures, tablets and capsules, namely, nutritional
supplements; oils, salves, concentrated pastes, tinctures,
tablets and capsules, namely, nutritional supplements each
containing oils derived from industrial hemp seed oil;
nutraceuticals for medicinal purposes for use as a dietary
supplement derived from industrial hemp seed oil;
nutraceuticals for wellness purposes for use as a dietary
supplement; nutraceuticals for wellness purposes for use as
a dietary supplement derived from industrial hemp seed oil;
medicated topical skin creams, bar and liquid soaps, bath
additives being bath salts, bath herbs, bath oils, body
creams, body oils, face and body lotions, face and body
milk, face lotion, and skin care preparations each
containing industrial hemp seed oil; medicated topical skin
creams, bar and liquid soaps, bath additives being bath
salts, bath herbs, bath oils, body creams, body oils, face
and body lotions, face and body milk, face lotion, and skin
care preparations all of the foregoing containing lipophilic
plant extracts and synthetic equivalents thereof; personal
sexual lubricants; personal sexual lubricants containing
lipophilic plant extracts and synthetic equivalents thereof;
medicated transdermal patches containing industrial hemp
seed oil for use in the treatment of pain, for relaxation,
for reducing stress and fatigue, for mood enhancement, for
maintaining general health and well-being, for relieving
anxiety, for relieving depression, as a sleep aid, for
appetite stimulation, for management of opioid addiction and
relief of epilepsy; medicated transdermal patches containing
lipophilic plant extracts and synthetic equivalents thereof;
medicated oils containing lipophilic plant extracts and
synthetic equivalents thereof; medicated oils derived from
industrial hemp seed oil; oral sprays for medicinal use for
the mouth containing lipophilic plant extracts and synthetic
equivalents thereof; veterinary preparations for medicinal
use containing industrial hemp seed oil for the treatment of
pain, for relaxation, for reducing stress and fatigue, for
mood enhancement, for maintaining general health and
well-being, for relieving anxiety, as a sleep aid, and for
appetite stimulation; veterinary preparations for medicinal
use containing lipophilic plant extracts and synthetic
equivalents thereof for the treatment of pain, for
relaxation, for reducing stress and fatigue, for mood
enhancement, for maintaining general health and well-being,
for relieving anxiety, as a sleep aid, and for appetite
stimulation; eye pads and patches for reducing inflammation
and swelling, namely, anti-inflammatories; medicated skin
care preparations for reducing inflammation. Food products, all of the foregoing containing lipophilic
plant extracts and synthetic equivalents thereof (term
considered too vague by the International Bureau - Rule 13
(2) (b) of the Regulations). Food products, namely, chocolates, cookies, brownies, candy,
candy mints, gummy candies and cereal based food energy
bars; tea; cocoa-based non-alcoholic beverages, coffee-based
non-alcoholic beverages; herbal tea beverages and tea-based
beverages; non-alcoholic beverages, namely infusions all of
the foregoing containing lipophilic plant extracts and
synthetic equivalents thereof. Smoothies, fruit beverages and fruit juices, and carbonated
soft drinks; smoothies, fruit beverages and fruit juices,
and carbonated soft drinks each containing (term considered
linguistically incorrect by the International Bureau - Rule
13 (2) (b) of the Regulations); powders for use in the
preparation of fruit-based beverages, and soft drinks;
powders for use in the preparation of fruit-based beverages,
and soft drinks; cannabis infused beverages; hemp-based
beverages; beer; drinking water; fruit juice; vegetable
juice; beverages containing hemp extracts, namely, beer,
juice, water, as lawfully permitted; energy drinks;
fruit-flavored non-alcoholic beverages; non-alcoholic
honey-based beverages; non-alcoholic carbonated beverages,
non-dairy soy beverages; non-alcoholic beverages, namely,
smoothies, fruit juices, vegetable juices, sports drinks,
isotonic beverages, flavored waters, vegetable juices,
carbonated water; beers and beer-based beverages; all of the
foregoing containing lipophilic plant extracts and synthetic
equivalents thereof.
16.
FAST-ACTING PLANT-BASED MEDICINAL COMPOUNDS AND NUTRITIONAL SUPPLEMENTS
Plant-based medicinal compounds or nutritional supplements in various carrier combinations are described. The carriers can include N-acylated fatty amino acids, penetration enhancers, and/or various other beneficial carriers. The plant-based composition/carrier combinations can create administration benefits.
A61K 31/352 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
A61K 9/00 - Medicinal preparations characterised by special physical form
A61K 31/352 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
A23L 33/105 - Plant extracts, their artificial duplicates or their derivatives
A61K 9/00 - Medicinal preparations characterised by special physical form
A61K 9/48 - Preparations in capsules, e.g. of gelatin, of chocolate
A61K 31/20 - Carboxylic acids, e.g. valproic acid having a carboxyl group bound to an acyclic chain of seven or more carbon atoms, e.g. stearic, palmitic or arachidic acid
Plant-based medicinal compounds or nutritional supplements in various carrier combinations are described. The carriers can include N-acylated fatty amino acids, penetration enhancers, and/or various other beneficial carriers. The plant-based composition/carrier combinations can create administration benefits.
A61K 31/20 - Carboxylic acids, e.g. valproic acid having a carboxyl group bound to an acyclic chain of seven or more carbon atoms, e.g. stearic, palmitic or arachidic acid
A61K 31/352 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
A23L 33/105 - Plant extracts, their artificial duplicates or their derivatives
Plant-based medicinal compounds or nutritional supplements in various carrier combinations are described. The carriers can include N-acylated fatty amino acids, penetration enhancers, and/or various other beneficial carriers. The plant-based composition/carrier combinations can create administration benefits.
A61K 36/73 - Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
A61K 36/00 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
A61K 31/352 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
A61K 9/00 - Medicinal preparations characterised by special physical form
Plant-based medicinal compounds or nutritional supplements in various carrier combinations are described. The carriers can include N-acylated fatty amino acids, penetration enhancers, and/or various other beneficial carriers. The plant-based composition/carrier combinations can create administration benefits.
A61K 31/20 - Carboxylic acids, e.g. valproic acid having a carboxyl group bound to an acyclic chain of seven or more carbon atoms, e.g. stearic, palmitic or arachidic acid
A61K 31/352 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
A23L 33/105 - Plant extracts, their artificial duplicates or their derivatives
Herbal compositions in various carrier combinations are described. The carriers can include N-acylated fatty amino acids, penetration enhancers, and/or various other beneficial carriers. The herbal composition/carrier combinations can create administration benefits.
A61K 31/122 - Ketones having the oxygen atom directly attached to a ring, e.g. quinones, vitamin K1, anthralin
A61K 31/165 - Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
A61K 31/20 - Carboxylic acids, e.g. valproic acid having a carboxyl group bound to an acyclic chain of seven or more carbon atoms, e.g. stearic, palmitic or arachidic acid
A61K 31/353 - 3,4-Dihydrobenzopyrans, e.g. chroman, catechin
A61K 31/475 - QuinolinesIsoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
A61K 31/7048 - Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin
Synthetic cannabinoid medicinal compounds or nutritional supplements in various carrier combinations are described. The carriers can include N-acylated fatty amino acids, penetration enhancers, and/or various other beneficial carriers. The synthetic cannabinoid composition/carrier combinations can create administration benefits.
A61K 31/352 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
A61P 25/00 - Drugs for disorders of the nervous system
23.
FAST-ACTING PLANT-BASED MEDICINAL COMPOUNDS AND NUTRITIONAL SUPPLEMENTS
Plant-based medicinal compounds or nutritional supplements in various carrier combinations are described. The carriers can include N-acylated fatty amino acids, penetration enhancers, and/or various other beneficial carriers. The plant-based composition/carrier combinations can create administration benefits.
A61K 31/197 - Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
A61K 31/352 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
A61K 47/06 - Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
